期刊文献+

Small interfering RNA-based molecular therapy of cancers 被引量:5

Small interfering RNA-based molecular therapy of cancers
下载PDF
导出
摘要 RNA interference(RNAi)has become a gold standard for validating gene function in basic life science research and provides a promising therapeutic modality for cancer and other diseases.This minireview focuses on the potential of small interfering RNAs(siRNAs)in anticancer treatment,including the establishment and screening of cancer-associated siRNA libraries and their applications in anticancer drug target discovery and cancer therapy.This article also describes the current delivery approaches of siRNAs using lipids,polymers,and,in particular,gold nanoparticles to induce significant gene silencing and tumor growth regression. RNA interference (RNAi) has become a gold standard for validating gene function in basic life science research and provides a promising therapeutic modality for cancer and other diseases. This mini- review focuses on the potential of small interfering RNAs (siRNAs) in anticancer treatment, including the establishment and screening of cancer-associated siRNA libraries and their applications in anticancer drug target discovery and cancer therapy. This article also describes the current delivery approaches of siRNAs using lipids, polymers, and, in particular, gold nanoparticles to induce significant gene silencing and tumor growth regression.
出处 《Chinese Journal of Cancer》 SCIE CAS CSCD 2013年第9期488-493,共6页
关键词 小干扰RNA 癌症治疗 SIRNAS 分子 RNA干扰 金纳米粒子 科学研究 基因功能 Cancer, siRNA, gene delivery, molecular therapy
  • 相关文献

参考文献39

  • 1Xie W, Liang C, Birchler JA. Inhibition of RNA interference and modulation of transposable element expression by cell death in Drosophila. Genetics, 2011,188:823-834. 被引量:1
  • 2Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21- nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 2001,411:494-498. 被引量:1
  • 3Soutschek J, Akinc A, Bramlage B, et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature, 2004,432:173-178. 被引量:1
  • 4Jagani H, Rao JV, Palanimuthu VR, et al. A nanoformulation of siRNA and its role in cancer therapy: in vitro and in vivo evaluation. Cell Mol Biol Lett, 2013,18:120-136. 被引量:1
  • 5De Fougerolles A, Vomlocher liP, Maraganore J, et al. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov, 2007,6:443-453. 被引量:1
  • 6Ye OR, Zhang YC, Peng XQ, et al. Silencing Notchal induces apoptosis and increases the chemosensitivity of prostate cancer cells to docetaxel through Bcl-2 and Bax. Oncol Lett, 2012,3:879- 884. 被引量:1
  • 7Bai Z, Zhang Z, Qu X, et al. Sensitization of breast cancer cells to taxol by inhibition of taxol resistance gene 1. Oncol Lett, 2012, 3:35-140. 被引量:1
  • 8Radia AM, Yaser AM, Ma X, et al. Specific siRNA targeting receptor for advanced glycation end products (RAGE) decreases proliferation in human breast cancer cell lines. Int J Mol Sci, 2013,11:7959-7978. 被引量:1
  • 9Sethi G, Pathak HB, Zhang H, et al. An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer. PLoS One, 2012,7:e47086. 被引量:1
  • 10Ashrafi K, Chang FY, Watts JL, et al. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature, 2003, 421:268-272. 被引量:1

同被引文献25

  • 1芮萌,刘长庭,于晓妉,侯春梅.应用RNAi技术沉默survivin基因对肺腺癌A549细胞的影响[J].解放军医学杂志,2007,32(6):595-597. 被引量:4
  • 2Manuel Rieber,Mary Strasberg-Rieber.p53 inactivation decreases dependence on estrogen/ERK signalling for proliferation but promotes EMT and susceptility to 3-bromopyruvate in ERα + breast cancer MCF-7 cells[J]. Biochemical Pharmacology . 2014 被引量:2
  • 3Bulent Ozpolat,Anil K. Sood,Gabriel Lopez-Berestein.Liposomal siRNA nanocarriers for cancer therapy[J]. Advanced Drug Delivery Reviews . 2013 被引量:2
  • 4Hua Zhou,Nada Binmadi,Ying-Hua Yang,Patrizia Proia,John Basile.Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progression[J]. Angiogenesis . 2012 (3) 被引量:2
  • 5Ch’ng Eweseng,Tomita Yasuhiko,Zhang Binglin,He Juxiang,Hoshida Yoshihiko,Qiu Ying,Morii Eiichi,Nakamichi Itsuko,Hamada Ken-ichiro,Ueda Takafumi,Aozasa Katsuyuki.Prognostic significance of CD100 expression in soft tissue sarcoma. Cancer . 2007 被引量:1
  • 6Nina Eissler,Charlotte Rolny.??The role of immune semaphorins in cancer progression(J)Experimental Cell Research . 2013 (11) 被引量:1
  • 7Hitesh Jagani,Venkata Josyula,Raghu Hariharapura,Vasanth Palanimuthu,Sagar Gang.??Nanoformulation of siRNA silencing Bcl-2 gene and its implication in cancer therapy(J)Arzneimittelforschung . 2011 (10) 被引量:1
  • 8P.N. Gabrovska,R.A. Smith,T. Tiang,S.R. Weinstein,L.M. Haupt,L.R. Griffiths.??Semaphorin–plexin signalling genes associated with human breast tumourigenesis(J)Gene . 2011 (2) 被引量:1
  • 9Jongbloets BC,Pasterkamp RJ.Semaphorin signalling during development. Development . 2014 被引量:1
  • 10Ch’ng Ewe Seng,Kumanogoh Atsushi.Roles of Sema4D and Plexin-B1 in tumor progression. Molecular Cancer . 2010 被引量:1

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部